Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yueshan Li

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Signal Transduction and Targeted Therapy|May 31, 2021
Small molecules in targeted cancer therapy: advances, challenges, and future perspectivesLei Zhong, Yueshan Li, Liang Xiong, et al.
Journal of Medicinal Chemistry|January 5, 2022
Discovery of 3,4-Dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one Derivatives as a New Class of Selective TNIK Inhibitors and Evaluation of Their Anti-Colorectal Cancer EffectsYueshan Li, Liting Zhang, Ruicheng Yang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 29, 2024
Conducting Composite Polymer-Based Solid-State Electrolyte with High Ion Conductivity via Amorphous Condensed Structure and Multiple Li<sup>+</sup> Transport ChannelsYueshan Li, Weihao Yuan, Fei Lu, et al.
Nature Communications|November 13, 2022
Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitorYueshan Li, Liting Zhang, Yifei Wang, et al.
Biochemical Pharmacology|March 15, 2017
3-O-(Z)-coumaroyloleanolic acid overcomes Cks1b-induced chemoresistance in lung cancer by inhibiting Hsp90 and MEK pathwaysHe Wang, Mingna Sun, Jiayi Guo, et al.
Journal of Medicinal Chemistry|November 28, 2018
Identification of 5-(2,3-Dihydro-1 H-indol-5-yl)-7 H-pyrrolo[2,3- d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis ModelYueshan Li, Yu Xiong, Guo Zhang, et al.
European Journal of Medicinal Chemistry|July 30, 2023
Discovery and structure-activity relationship studies of novel α-ketoamide derivatives targeting the SARS-CoV-2 main proteaseChong Huang, Rui Zeng, Jingxin Qiao, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2024
Structure-based identification of a G protein-biased allosteric modulator of cannabinoid receptor CB1Siyuan Shen, Chao Wu, Guifeng Lin, et al.
Nature Communications|January 26, 2026
YL1004 is a SARS-CoV-2 papain-like protease inhibitor with immunomodulatory and antiviral activity in miceJinshan Nan, Huiping Shuai, Jingxin Qiao, et al.
Science Translational Medicine|February 4, 2026
Small-molecule inhibition of YTHDC1 as a strategy against acute myeloid leukemia in mouse modelsHailin Zhang, Yueshan Li, Yin Zhao, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Signal Transduction and Targeted Therapy|May 31, 2021
Small molecules in targeted cancer therapy: advances, challenges, and future perspectivesLei Zhong, Yueshan Li, Liang Xiong, et al.
Journal of Medicinal Chemistry|January 5, 2022
Discovery of 3,4-Dihydrobenzo[<i>f</i>][1,4]oxazepin-5(2<i>H</i>)-one Derivatives as a New Class of Selective TNIK Inhibitors and Evaluation of Their Anti-Colorectal Cancer EffectsYueshan Li, Liting Zhang, Ruicheng Yang, et al.
Small (Weinheim an Der Bergstrasse, Germany)|August 29, 2024
Conducting Composite Polymer-Based Solid-State Electrolyte with High Ion Conductivity via Amorphous Condensed Structure and Multiple Li<sup>+</sup> Transport ChannelsYueshan Li, Weihao Yuan, Fei Lu, et al.
Nature Communications|November 13, 2022
Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitorYueshan Li, Liting Zhang, Yifei Wang, et al.
Biochemical Pharmacology|March 15, 2017
3-O-(Z)-coumaroyloleanolic acid overcomes Cks1b-induced chemoresistance in lung cancer by inhibiting Hsp90 and MEK pathwaysHe Wang, Mingna Sun, Jiayi Guo, et al.
Journal of Medicinal Chemistry|November 28, 2018
Identification of 5-(2,3-Dihydro-1 H-indol-5-yl)-7 H-pyrrolo[2,3- d]pyrimidin-4-amine Derivatives as a New Class of Receptor-Interacting Protein Kinase 1 (RIPK1) Inhibitors, Which Showed Potent Activity in a Tumor Metastasis ModelYueshan Li, Yu Xiong, Guo Zhang, et al.
European Journal of Medicinal Chemistry|July 30, 2023
Discovery and structure-activity relationship studies of novel α-ketoamide derivatives targeting the SARS-CoV-2 main proteaseChong Huang, Rui Zeng, Jingxin Qiao, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2024
Structure-based identification of a G protein-biased allosteric modulator of cannabinoid receptor CB1Siyuan Shen, Chao Wu, Guifeng Lin, et al.
Nature Communications|January 26, 2026
YL1004 is a SARS-CoV-2 papain-like protease inhibitor with immunomodulatory and antiviral activity in miceJinshan Nan, Huiping Shuai, Jingxin Qiao, et al.
Science Translational Medicine|February 4, 2026
Small-molecule inhibition of YTHDC1 as a strategy against acute myeloid leukemia in mouse modelsHailin Zhang, Yueshan Li, Yin Zhao, et al.
Pageof 3